234 related articles for article (PubMed ID: 21994039)
1. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications.
Airoldi I; Raffaghello L; Piovan E; Cocco C; Carlini B; Amadori A; Corrias MV; Pistoia V
Clin Cancer Res; 2006 Jan; 12(1):77-82. PubMed ID: 16397027
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.
Morandi F; Scaruffi P; Gallo F; Stigliani S; Moretti S; Bonassi S; Gambini C; Mazzocco K; Fardin P; Haupt R; Arcamone G; ; Pistoia V; Tonini GP; Corrias MV
PLoS One; 2012; 7(1):e29922. PubMed ID: 22253825
[TBL] [Abstract][Full Text] [Related]
4. [The TH, ELAVL4 and GD2 gene expression as diagnostic markers of bone marrow lesions in patients with neuroblastoma].
Druĭ AE; Tsaur GA; Popov AM; Tuponogov SN; Shorikov EV; Tsvirenko SV; Savel'ev LI; Fechina LG
Vopr Onkol; 2012; 58(4):514-20. PubMed ID: 23607207
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
[TBL] [Abstract][Full Text] [Related]
6. Combined use of multiparametric flow cytometry and cytomorphology to enhance detection of neuroblastoma metastatic cells in bone marrow.
Manenq C; Lesesve JF; Dreumont N; Massin F; Salignac S; Mansuy L; Chastagner P; Latger-Cannard V; Broséus J
Int J Lab Hematol; 2020 Feb; 42(1):52-60. PubMed ID: 31821742
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
[TBL] [Abstract][Full Text] [Related]
8. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
9. [The morphological assessment of bone marrow infiltration in neuroblastoma].
Brisigotti M; Medicina D; Bercich L; Bonetti MF; Fabbretti G; Gambini C; Lo Piccolo MS; Milanaccio C; Rosanda C; Garaventa A; De Bernardi B; Callea F
Pediatr Med Chir; 1998; 20(3):169-74. PubMed ID: 9744007
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bone marrow as a metastatic site of human neuroblastoma.
Morandi F; Corrias MV; Pistoia V
Ann N Y Acad Sci; 2015 Jan; 1335():23-31. PubMed ID: 25315505
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
Bregni M; Fleischhauer K; Bernardi M; Pescarollo A; Guggiari E; Lunghi F; Deola S; Scaramuzza S; Re F; Setola E; Monari M; Mazzi B; Servida P; Corradini P; Peccatori J
Bone Marrow Transplant; 2006 Feb; 37(3):311-5. PubMed ID: 16400340
[TBL] [Abstract][Full Text] [Related]
12. Control of neuroblastoma cell proliferation and differentiation by human bone marrow.
Hahn T; Or R; Bruchelt G; Malach L; Karov Y; Lefshitz-Mercer B; Evron R; Barak Y
Cancer; 1996 Jun; 77(12):2614-21. PubMed ID: 8640713
[TBL] [Abstract][Full Text] [Related]
13. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
Cheung IY; Sahota A; Cheung NK
Cancer; 2004 Nov; 101(10):2303-8. PubMed ID: 15484213
[TBL] [Abstract][Full Text] [Related]
14. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
15. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.
Garcia-Gerique L; García M; Garrido-Garcia A; Gómez-González S; Torrebadell M; Prada E; Pascual-Pasto G; Muñoz O; Perez-Jaume S; Lemos I; Salvador N; Vila-Ubach M; Doncel-Requena A; Suñol M; Carcaboso AM; Mora J; Lavarino C
BMC Cancer; 2022 Jun; 22(1):669. PubMed ID: 35715791
[TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Kramer K; Kushner B; Heller G; Cheung NK
Cancer; 2001 Apr; 91(8):1510-9. PubMed ID: 11301399
[TBL] [Abstract][Full Text] [Related]
17. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
[TBL] [Abstract][Full Text] [Related]
18. Molecular signature associated with bone marrow micrometastasis in human breast cancer.
Woelfle U; Cloos J; Sauter G; Riethdorf L; Jänicke F; van Diest P; Brakenhoff R; Pantel K
Cancer Res; 2003 Sep; 63(18):5679-84. PubMed ID: 14522883
[TBL] [Abstract][Full Text] [Related]
19. Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers.
Cheung IY; Barber D; Cheung NK
Clin Cancer Res; 1998 Nov; 4(11):2801-5. PubMed ID: 9829745
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease is a prognostic marker for neuroblastoma with bone marrow infiltration.
Cai JY; Pan C; Tang YJ; Chen J; Ye QD; Zhou M; Xue H; Tang JY
Am J Clin Oncol; 2012 Jun; 35(3):275-8. PubMed ID: 21537148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
